Pharmacare reports the 2018 First Quarter Financial Results
April 26, 2018
Pharmacare is pleased to release its 1st quarterly financial results of 2018 ensuing the 2nd Board Meeting Conference taking place since the beginning of the present year.
Ramallah--(BUSINESS WIRE)--—Pharmacare PLC announces its release of its first quarter 2018 financial results today, Wednesday, at 10:30 a.m. ET.
Pharmacare will host a conference joining all board members, at 10:30 a.m. ET to discuss its first quarter 2018 results and overall business environment. A tour to explore the new recently established within the main building at Pharmacare PLC should follow at 14:30.
Pharmacare PLC (PCP), a leading pharmaceutical company within the State of Palestine specialising in the development, production and marketing of generic and branded pharmaceuticals; as well as the local distribution of products of multinational pharmaceutical companies within Palestine. Pharmacare enjoys a firmly established local presence and operates through a carefully tailored network of subsidiaries; it expanded into EU and other European and International markets. Throughout the past three decades since its foundation, PCP has succeeded to demonstrate a model role in the Palestinian economy and a consistently growing profile over its home market. With over 150 items and 330 employees, PCP supplies premium affordable medicines to the local population. PCP further reflects increasing returns to its shareholders and continues to develop as an international business covering wide-range geographical locations worldwide. Financial Statement